Nov 3
Earnings call
Rights issue targets liquidity as Q2 EBITDA margin falls
Cameron Fine Sciences Limited approved a rights issue of 250 crores to stabilize working capital and support growth. Q2 EBITDA margin fell from 3.4% to 0.5%; management expects Q4 revenue of 600 crores and EBITDA of 60 crore plus.